Daily non-political popular news in brief.

Stanford researchers identify immune dysfunction in melanoma patients

Researchers at Stanford have begun to shed light on why the human immune system isn't able to stop such cancers as melanoma, suggesting answers that could pave the way for better treatment of this often-fatal illness. In a small study, the scientists found that the immune cells in a majority of people with this deadly skin cancer fail to respond properly to a molecule called interferon, which normally activates the immune system.

Read more »

Keywords: stanford, researchers, identify, immune, dysfunction, melanoma, patients, researcher, patient

« Previous | Next »

Similar news on "Stanford researchers identify immune dysfunction in melanoma patients":

1. New test helps identify hepatitis C patients at high risk of developing cirrhosis
   04-27-2007 · EurekAlert!
   A researcher at the Stanford University School of Medicine has helped confirm the reliability of a new test for liver disease that is ushering in the long-promised era of personalized medicine based on each individual's genetic makeup.
   Similar news · Read more »
   
2. New vaccine stimulates colorectal cancer patient's immune systems to fight cancerous cells
   11-15-2006 · EurekAlert!
   British researchers have developed a vaccine that stimulates colorectal cancer patients' immune systems to fight cancerous cells.
   Similar news · Read more »
   
3. Personalized diets may offer relief to advanced cancer patients
   03-09-2007 · EurekAlert!
   Researchers at the University of Alberta studying the effects of chemotherapy and radiation therapy on the senses report that most advanced cancer patients experience unique and persistent taste and smell abnormalities, believed to be a key factor in malnutrition and poor quality of life. Their study suggests that every patient with chemosensory dysfunction has unique symptoms, and a diet tailored to his/her needs would likely improve quality of life.
   Similar news · Read more »
   
4. Pancreatic cancer vaccine halts progression of disease in some patients
   04-17-2007 · EurekAlert!
   A dendritic cell-based therapeutic vaccine for pancreatic cancer developed by researchers at the University of Pittsburgh School of Medicine has successfully stalled the disease from progressing in a handful of patients three years post-vaccination. The results, part of a press briefing on cancer vaccines held at the annual meeting of the American Association of Cancer Research, provide promising evidence that the vaccine can trigger a patient's own immune system to rally against pancreatic cancer.
   Similar news · Read more »
   
5. From clinical cancer research: rethinking therapeutic cancer vaccine trials
   07-03-2007 · EurekAlert!
   Ongoing therapeutic cancer vaccine trials have yet to show evidence of vaccines spurring a patient's immune system to shrink tumors -- yet patients who receive these vaccines in trials tend to live longer and respond better to subsequent treatment. In the July 1 issue of Clinical Cancer Research, a journal of the American Association for Cancer Research, a team of National Cancer Institute researchers asks a fundamental question: are we looking at cancer vaccine trials the wrong way?
   Similar news · Read more »
   
6. Scientists harness diptheria toxin and interleukin 2 to help the immune system attack melanoma
   11-09-2006 · EurekAlert!
   Researchers investigating ways of prompting the immune system to recognise and kill tumour cells have found that a drug containing parts of the diptheria toxin appears to work well in patients with advanced melanoma, according to research presented at the 18th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics on Thursday.
   Similar news · Read more »
   
7. Study of drug therapy for compulsive buying yields a puzzle, Stanford researcher says
   03-13-2007 · EurekAlert!
   Researchers at the Stanford University School of Medicine say they are puzzled by findings from their new study indicating that an antidepressant, which previously showed promise in treating a behavioral disorder known as compulsive buying, did not result in a sustained benefit for the patients who took it.
   Similar news · Read more »
   
8. New biologic treatment for tennis elbow may replace surgery for chronic sufferers
   10-23-2006 · EurekAlert!
   "Tennis elbow" isn't restricted to tennis players; it's a common, chronic problem for people whose activities require strong gripping or repetitive wrist motions. A novel biologic treatment of injecting the patient's own platelets into the affected tendon proves successful and gives patients another treatment option before undergoing surgery. The procedure has wide application for healing of other medical conditions, say researchers from Stanford University.
   Similar news · Read more »
   
9. Stanford study finds no conclusive benefit from treating kleptomania
   03-14-2007 · EurekAlert!
   A small clinical trial of a medication to treat kleptomania has failed to find any conclusive benefit for patients with the impulsive stealing disorder, according to researchers at the Stanford University School of Medicine
   Similar news · Read more »
   
10. BMI criteria for obesity surgery should be lowered, UT Southwestern researcher suggests
    12-18-2007 · EurekAlert!
    UT Southwestern Medical Center researchers have found that the existing body mass index criteria for obesity surgery often excludes a group of obese patients at risk of cardiovascular disease.
    Similar news · Read more »